Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Avon Faces Potential High Penalties Under SEC Deal; Q3 Sales Down 7%
Nov 04 2013
•
By
Katie Saunders
More from Archive
More from HBW Insight